From here to 2025: Personalised medicine and healthcare for an immediate future

Publication date: June 2018Source: Journal of Cancer Policy, Volume 16Author(s): Denis HorganAbstractTaking real advantage of Europe’s excellence to improve citizens’ lives presents challenges that Europe’s policymakers have not yet fully met. The European Union and Member States have shown some clarity of assessment in recognising the needs, and some laudable determination to improve the situation, and it has intermittently taken some real steps to deliver on its ambitions to turn its excellence into valuable innovations for the benefit of citizens. But as we move towards the third decade of the 21st century, Europe still faces some harsh choices about whether it is actually going to do what it has so often discussed to allow the EU to be a center for health innovation.The EU has to make some firm decisions about what deserves support - and where. It must turn words into deeds about promoting effective links between investment that will facilitate inward investment to the EU. That requires a sharper focus about developing and retaining the right skill sets in Europe, about funding innovation, about creating an encouraging regulatory environment, and about building greater public understanding and engagement. The framework document represents a mission oriented approach to integrating personalised medicine and personalised healthcare in Europe.
Source: Journal of Cancer Policy - Category: Cancer & Oncology Source Type: research